Doi.org/10.1517/14656566.2012.730519

Target ArticleEdit

A randomized, double-blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and beta-cell function.  ; Giuseppe Derosa Anna Carbone Angela D'Angelo Fabrizio Querci Elena Fogari Arrigo F G Cicero Pa; NULL; 10/15/2012; https://doi.org/10.1517/14656566.2012.730519

ReasonsEdit

Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.